1. Home
  2. CUE
  3. CUE News

Latest Cue Biopharma Inc. (CUE) News on December 18, 2024

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CUE

GlobeNewswire

19 days ago

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
CUE

GlobeNewswire

23 days ago

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations
CUE

Simply Wall St.

a month ago

Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations

CUE

MT Newswires

a month ago

Jefferies Cuts Price Target on Cue Biopharma to $4 From $6, Maintains Buy Rating

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates
CUE

Zacks

a month ago

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
CUE

GlobeNewswire

a month ago

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Cue Biopharma Announces Strategic Organizational Transition
CUE

GlobeNewswire

a month ago

Cue Biopharma Announces Strategic Organizational Transition

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
CUE

GlobeNewswire

a month ago

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
CUE

GlobeNewswire

a month ago

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89%
CUE

Simply Wall St.

2 months ago

Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89%

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
CUE

GlobeNewswire

2 months ago

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

CUE

MT Newswires

3 months ago

Cue Biopharma Prices $12 Million Offering

Cue Biopharma Announces Pricing of $12.0 Million Public Offering
CUE

GlobeNewswire

3 months ago

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

Cue Biopharma Announces Proposed Public Offering
CUE

GlobeNewswire

3 months ago

Cue Biopharma Announces Proposed Public Offering

CUE

MT Newswires

3 months ago

Cue Biopharma Queues Up Stock Sale

Cue Biopharma Announces Proposed Public Offering
CUE

GlobeNewswire

3 months ago

Cue Biopharma Announces Proposed Public Offering

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
CUE

GlobeNewswire

3 months ago

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
CUE

GlobeNewswire

3 months ago

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference

CUE

Thomson Reuters StreetEvents

4 months ago

Q2 2024 Cue Biopharma Inc Earnings Call

CUE

MT Newswires

4 months ago

Cue Biopharma Q2 Net Loss Narrows, Revenue Rises

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
CUE

GlobeNewswire

4 months ago

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
CUE

Zacks

4 months ago

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Cue Biopharma to Host Business Update Call and Webcast
CUE

GlobeNewswire

4 months ago

Cue Biopharma to Host Business Update Call and Webcast

Cue Biopharma downsizes to focus on autoimmune pipeline
CUE

Pharmaceutical Technology

5 months ago

Cue Biopharma downsizes to focus on autoimmune pipeline

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements
CUE

GlobeNewswire

5 months ago

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?
CUE

Zacks

6 months ago

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock?

Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
CUE

GlobeNewswire

6 months ago

Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
CUE

GlobeNewswire

6 months ago

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024

Cue Biopharma First Quarter 2024 Earnings: Beats Expectations
CUE

Simply Wall St.

7 months ago

Cue Biopharma First Quarter 2024 Earnings: Beats Expectations

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
CUE

GlobeNewswire

7 months ago

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
CUE

GlobeNewswire

7 months ago

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference
CUE

GlobeNewswire

7 months ago

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference

Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks
CUE

Zacks

8 months ago

Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
CUE

GlobeNewswire

8 months ago

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now
CUE

Zacks

8 months ago

Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now

CUE

Thomson Reuters StreetEvents

8 months ago

Q4 2023 Cue Biopharma Inc Earnings Call

CUE

GuruFocus.com

8 months ago

Cue Biopharma Inc (CUE) Q4 2023 Earnings Call Transcript Highlights: Strategic Alliances and ...

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
CUE

GlobeNewswire

8 months ago

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

Cue Biopharma to Host Business Update Call and Webcast
CUE

GlobeNewswire

9 months ago

Cue Biopharma to Host Business Update Call and Webcast

Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline
CUE

Zacks

9 months ago

Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
CUE

GlobeNewswire

10 months ago

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?
CUE

Zacks

10 months ago

Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
CUE

GlobeNewswire

10 months ago

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?
CUE

Zacks

a year ago

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

What To Expect From Magnachip’s (MX) Q4 Earnings
CUE

StockStory

a year ago

What To Expect From Magnachip’s (MX) Q4 Earnings

Red Robin (RRGB) Rises Higher Than Market: Key Facts
CUE

Zacks

a year ago

Red Robin (RRGB) Rises Higher Than Market: Key Facts

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
CUE

PR Newswire

a year ago

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

Is Five Point Holdings (FPH) Well Positioned for Success in 2024 and Beyond?
CUE

Insider Monkey

a year ago

Is Five Point Holdings (FPH) Well Positioned for Success in 2024 and Beyond?

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
CUE

Simply Wall St.

a year ago

Bridgewater Bancshares Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem
CUE

PR Newswire

a year ago

Cango Announces Strategic Partnership with Caocao Mobility for Next-Generation Smart Mobility Ecosystem

PCB Bancorp Reports Earnings of $5.9 million for Q4 2023 and $30.7 million for 2023
CUE

Business Wire

a year ago

PCB Bancorp Reports Earnings of $5.9 million for Q4 2023 and $30.7 million for 2023

Grindrod Shipping Holdings Ltd. Announces Ship Sales
CUE

GlobeNewswire

a year ago

Grindrod Shipping Holdings Ltd. Announces Ship Sales

Murphy Oil (MUR) Lags Q4 Earnings Estimates
CUE

Zacks

a year ago

Murphy Oil (MUR) Lags Q4 Earnings Estimates

Owning 70% in iHuman Inc. (NYSE:IH) means that insiders are heavily invested in the company's future
CUE

Simply Wall St.

a year ago

Owning 70% in iHuman Inc. (NYSE:IH) means that insiders are heavily invested in the company's future

AI Shows Signs of Maturity, Expansion in Brazil
CUE

Business Wire

a year ago

AI Shows Signs of Maturity, Expansion in Brazil

Evolution Petroleum (EPM) Stock Dips While Market Gains: Key Facts
CUE

Zacks

a year ago

Evolution Petroleum (EPM) Stock Dips While Market Gains: Key Facts

Five Point Holdings, LLC (NYSE:FPH) Q4 2023 Earnings Call Transcript
CUE

Insider Monkey

a year ago

Five Point Holdings, LLC (NYSE:FPH) Q4 2023 Earnings Call Transcript

Comtech (CMTL) Soars 15.3%: Is Further Upside Left in the Stock?
CUE

Zacks

a year ago

Comtech (CMTL) Soars 15.3%: Is Further Upside Left in the Stock?

Should You Think About Buying Gray Television, Inc. (NYSE:GTN) Now?
CUE

Simply Wall St.

a year ago

Should You Think About Buying Gray Television, Inc. (NYSE:GTN) Now?

Armour Residential REIT (ARR) Stock Falls Amid Market Uptick: What Investors Need to Know
CUE

Zacks

a year ago

Armour Residential REIT (ARR) Stock Falls Amid Market Uptick: What Investors Need to Know

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement
CUE

GlobeNewswire

a year ago

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement

With 52% institutional ownership, American Public Education, Inc. (NASDAQ:APEI) is a favorite amongst the big guns
CUE

Simply Wall St.

a year ago

With 52% institutional ownership, American Public Education, Inc. (NASDAQ:APEI) is a favorite amongst the big guns

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CUE

GlobeNewswire

a year ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
CUE

GlobeNewswire

a year ago

ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024

Arbe Celebrates Milestone Achievements as Sensrad Announces Major Customer Orders for Revolutionary Radar Technology
CUE

GlobeNewswire

a year ago

Arbe Celebrates Milestone Achievements as Sensrad Announces Major Customer Orders for Revolutionary Radar Technology

Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up
CUE

Zacks

a year ago

Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up

Cue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years ago
CUE

Simply Wall St.

a year ago

Cue Biopharma (NASDAQ:CUE) investors are sitting on a loss of 80% if they invested three years ago

Kingsway Publishes Updated Investor Presentation To Company Website
CUE

ACCESSWIRE

a year ago

Kingsway Publishes Updated Investor Presentation To Company Website

Vera Bradley, Inc. Announces Seasoned Retail Executive Bradley Weston To Join Board Of Directors
CUE

GlobeNewswire

a year ago

Vera Bradley, Inc. Announces Seasoned Retail Executive Bradley Weston To Join Board Of Directors

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
CUE

GlobeNewswire

a year ago

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

Four New Produce Companies Join Expanding ReposiTrak Traceability Network to Share Traceability Data With Retailers, Wholesalers
CUE

Business Wire

a year ago

Four New Produce Companies Join Expanding ReposiTrak Traceability Network to Share Traceability Data With Retailers, Wholesalers

CUE

GlobeNewswire

a year ago

GENFIT Announces 2024 Financial Calendar

While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12% gain, individual investors stood to gain the most
CUE

Simply Wall St.

a year ago

While institutions invested in ProQR Therapeutics N.V. (NASDAQ:PRQR) benefited from last week's 12% gain, individual investors stood to gain the most

Invesco Municipal Trust's Dividend Analysis
CUE

GuruFocus.com

a year ago

Invesco Municipal Trust's Dividend Analysis

The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable
CUE

Simply Wall St.

a year ago

The past three years for Codexis (NASDAQ:CDXS) investors has not been profitable

Public companies account for 50% of Fanhua Inc.'s (NASDAQ:FANH) ownership, while individual investors account for 31%
CUE

Simply Wall St.

a year ago

Public companies account for 50% of Fanhua Inc.'s (NASDAQ:FANH) ownership, while individual investors account for 31%

Calculating The Intrinsic Value Of El Pollo Loco Holdings, Inc. (NASDAQ:LOCO)
CUE

Simply Wall St.

a year ago

Calculating The Intrinsic Value Of El Pollo Loco Holdings, Inc. (NASDAQ:LOCO)

Natural Grocers® Invites Customers to Annual Resolution Reset Event, January 16-20, 2024
CUE

PR Newswire

a year ago

Natural Grocers® Invites Customers to Annual Resolution Reset Event, January 16-20, 2024

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
CUE

GlobeNewswire

a year ago

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

Kings River Packing Becomes First in Citrus to Implement Traceability
CUE

Business Wire

a year ago

Kings River Packing Becomes First in Citrus to Implement Traceability

Sterling Bancorp, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, January 24, 2024
CUE

Business Wire

a year ago

Sterling Bancorp, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, January 24, 2024

Investors in Viemed Healthcare (NASDAQ:VMD) have seen decent returns of 83% over the past five years
CUE

Simply Wall St.

a year ago

Investors in Viemed Healthcare (NASDAQ:VMD) have seen decent returns of 83% over the past five years

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)
CUE

PR Newswire

a year ago

INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

Gannett Co., Inc. (NYSE:GCI) is largely controlled by institutional shareholders who own 57% of the company
CUE

Simply Wall St.

a year ago

Gannett Co., Inc. (NYSE:GCI) is largely controlled by institutional shareholders who own 57% of the company

Pinstripes Completes Business Combination with Banyan Acquisition Corporation and Will Begin Trading on New York Stock Exchange
CUE

Business Wire

a year ago

Pinstripes Completes Business Combination with Banyan Acquisition Corporation and Will Begin Trading on New York Stock Exchange

Reasons to Add Global Water Resources (GWRS) to Your Portfolio Now
CUE

Zacks

a year ago

Reasons to Add Global Water Resources (GWRS) to Your Portfolio Now

Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023
CUE

GlobeNewswire

a year ago

Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023

Primis Financial Corp. Announces Reauthorization of Stock Repurchase Program
CUE

PR Newswire

a year ago

Primis Financial Corp. Announces Reauthorization of Stock Repurchase Program

ChoiceOne Bank Announces Kiwanis Inclusive Playground Commitment
CUE

PR Newswire

a year ago

ChoiceOne Bank Announces Kiwanis Inclusive Playground Commitment

Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design
CUE

GlobeNewswire

a year ago

Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier Gene Therapy—Pivotal Phase 3 Study Design

Gilead (GILD), Compugen Collaborate for Immunotherapy Program
CUE

Zacks

a year ago

Gilead (GILD), Compugen Collaborate for Immunotherapy Program

Forge Enhances Institutional Focus with Appointment of Chris Lane
CUE

Business Wire

a year ago

Forge Enhances Institutional Focus with Appointment of Chris Lane

Heritage Announces Closing of Primary Public Offering of Shares of Common Stock and Concurrent Private Placement
CUE

PR Newswire

a year ago

Heritage Announces Closing of Primary Public Offering of Shares of Common Stock and Concurrent Private Placement

EMX Announces Early Repayment of the US$10M Sprott Credit Facility
CUE

Newsfile

a year ago

EMX Announces Early Repayment of the US$10M Sprott Credit Facility

Investors Aren't Entirely Convinced By Cango Inc.'s (NYSE:CANG) Revenues
CUE

Simply Wall St.

a year ago

Investors Aren't Entirely Convinced By Cango Inc.'s (NYSE:CANG) Revenues

WeaveGrid and Wallbox Partner to Give Customers Access to Wind-Powered EV Charging at Xcel Energy
CUE

Business Wire

a year ago

WeaveGrid and Wallbox Partner to Give Customers Access to Wind-Powered EV Charging at Xcel Energy

Shareholders in El Pollo Loco Holdings (NASDAQ:LOCO) are in the red if they invested three years ago
CUE

Simply Wall St.

a year ago

Shareholders in El Pollo Loco Holdings (NASDAQ:LOCO) are in the red if they invested three years ago

Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company
CUE

Business Wire

a year ago

Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company

Insider Sell Alert: EVP Scott Schatz Sells 14,138 Shares of Townsquare Media Inc (TSQ)
CUE

GuruFocus.com

a year ago

Insider Sell Alert: EVP Scott Schatz Sells 14,138 Shares of Townsquare Media Inc (TSQ)

Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
CUE

Zacks

a year ago

Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up

Share on Social Networks: